Please fill out the form below to get started and we’ll
be in touch within 24 hours with next steps.
Tecfidera® is prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It’s unknown if Tecfidera® is safe and effective in children under 18 years of age.
Tecfidera® is administered twice per day, orally, for 7 days at 120 mg as the starting dose. Then, the maintenance dose after 7 days is 240 mg twice per day.
Tecfidera® may cause serious side effects including allergic reactions, PML, decreased white blood cell count, liver problems, herpes zoster infections (shingles), and other serious infections.
We believe that high deductibles and copays shouldn’t prevent anyone from receiving the medications they need. That’s why at QuickRx, we offer a Movement Disorder Copay Assistance Program. This is designed to help patients reduce their copays and out-of-pocket costs for their medication. Our program partners with various foundations and manufacturer assistance programs to help make a patient’s medication affordable.
Here are the ways to apply for the program:
Tecfidera® helps patients with MS by being a delayed-release capsule taken orally.
Tecfidera® comes in pill form.
Tecfidera® is administered orally through tablet form.
You need to take Tecfidera® exactly as prescribed by your doctor. It is critical to maintain your pill routine. If you experience any adverse side effects, talk to your doctor immediately.